Cargando…
Vascular functional tests and preemptive medicine
Autores principales: | Tanaka, Atsushi, Toyoda, Shigeru, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732751/ https://www.ncbi.nlm.nih.gov/pubmed/32884123 http://dx.doi.org/10.1038/s41440-020-00546-5 |
Ejemplares similares
-
Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
por: Sawami, Kosuke, et al.
Publicado: (2022) -
Preemptive Medicine for Cerebral Aneurysms
por: AOKI, Tomohiro, et al.
Publicado: (2016) -
Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT)
por: Tanaka, Atsushi, et al.
Publicado: (2023) -
Epigenomic-basis of Preemptive Medicine for Neurodevelopmental Disorders
por: Kubota, Takeo, et al.
Publicado: (2015) -
N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study
por: Tanaka, Atsushi, et al.
Publicado: (2017)